DMK
ZYME icon

David M. Knott’s Zymeworks ZYME Stock Holding History

David M. Knott’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$116K Buy
+4,000
New +$133K 0.04% 114

Other funds holding ZYME

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

David M. Knott's ZYME Position: Q3 2021 in Review

David M. Knott opened a new position in Zymeworks (ZYME) in Q3 2021: 4,000 shares worth $116K. The stake represents 0.04% of the portfolio and ranks #114 among its holdings.

123 funds tracked by Wall St. Rank hold ZYME as of Q3 2021.

  • David M. Knott held 4,000 shares of Zymeworks worth $116K as of Q3 2021.
  • Zymeworks was a new David M. Knott position in Q3 2021.
  • Zymeworks made up 0.04% of David M. Knott's portfolio in Q3 2021, its #114 holding.
  • 123 funds tracked by Wall St. Rank held Zymeworks as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.